Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections

Clin Infect Dis. 2013 Aug;57(3):359-61. doi: 10.1093/cid/cit262. Epub 2013 Apr 24.
No abstract available

Keywords: Acinetobacter baumannii; antimicrobial resistance; colistin; rifampicin.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter baumannii / drug effects*
  • Anti-Bacterial Agents / therapeutic use*
  • Colistin / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Male
  • Rifampin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Rifampin
  • Colistin